Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Non-Current Deferred Tax Liability (2023)

Day One Biopharmaceuticals (DAWN) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with $75000.0 as the latest value for Q4 2023.

  • For Q4 2023, Non-Current Deferred Tax Liability changed N/A year-over-year to $75000.0; the TTM value through Dec 2023 reached $75000.0, changed N/A, while the annual FY2023 figure was $75000.0, N/A changed from the prior year.
  • Non-Current Deferred Tax Liability was $75000.0 for Q4 2023 at Day One Biopharmaceuticals.
  • The five-year high for Non-Current Deferred Tax Liability was $75000.0 in Q4 2023, with the low at $75000.0 in Q4 2023.